European Intention to Grant on applicator patent makes Sofdra® more attractive for ex-US commercialization
The decision strengthens Botanix's European IP position & is expected to enhance the Company's value proposition for potential ex-US commercialization pathways Botanix Pharmaceuticals Limited (ASX:BOT) PHOENIX, AZ, UNITED STATES, July 7, …